Regulatory B cells in autoimmunity: developments and controversies.
Over a decade has now passed since the concept of B cells with a regulatory function was resurrected--B cells that produce antibodies with a suppressive effect were first reported in the 1960s and suppressor B cells in the 2000s. In the meantime, some aspects of regulatory B (B(REG))-cell biology have been elucidated. Not only have scientists begun to unravel the mechanism of how B(REG) cells suppress immune responses and which cells they target, but their ontogeny and development has also begun to be determined. To date, key roles for B(REG) cells have been identified in the regulation of several immune-mediated processes, including autoimmunity and responses to infectious disease and cancer. This Review highlights these advances in the study of B(REG) cells, and outlines what is known about their phenotype as well as their suppressive role in autoimmunity from studies in both mice and humans. A particular emphasis is placed on B(REG)-cell function in rheumatic diseases.
Mauri
Claudia
C
Centre for Rheumatology Research, Department of Medicine, University College London, 46 Cleveland Street, London W1T 4JF, UK. c.mauri@ucl.ac.uk
Blair
Paul A
PA
D000818:Animals; D015551:Autoimmunity / Q000502:physiology*; D001402:B-Lymphocytes / Q000502:physiology*; D004195:Disease Models, Animal; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism; D051379:Mice; D010641:Phenotype; D012216:Rheumatic Diseases / Q000503:physiopathology*
D016753:Interleukin-10